Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Toronto Stock Exchange  >  Transition Therapeutics Inc    TTH

 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Toronto Stock Exchange
07/24/2015 07/27/2015 07/28/2015 07/29/2015 07/30/2015 Date
2.9 2.89 2.94 2.86 2.83 Last
3015 2730 5200 1000 1000 Volume
-2.68% -0.34% +1.73% -2.72% -1.05% Change
Financials ( CAD)
Sales 2015 1,25 M
EBIT 2015 -48,2 M
Net income 2015 -44,8 M
Debt 2015 -
Yield 2015 -
Sales 2016 2,50 M
EBIT 2016 -18,1 M
Net income 2016 -13,3 M
Debt 2016 -
Yield 2016 -
PER 2015 -
PER 2016
Capi. / Sales 2015 88,0x
Capi. / Sales 2016 44,0x
Capitalization 110 M
More Financials
Company
Transition Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapeutics for disease indications with large markets.It operates through research and development of therapeutic agents segment.The company's products include ELND005 for the treatment of alzheimer's... 
Sector
Pharmaceuticals
Calendar
09/28Earnings Release
More about the company
Latest news on TRANSITION THERAPEUTICS IN
06/24 TRANSITION THERAPEUTICS : Announces Results of Clinical Study of ELND005 in Agit..
06/16 TRANSITION THERAPEUTICS : Appoints Carl Damiani as President
05/26 TRANSITION THERAPEUTICS : to Present at the Jefferies 2015 Healthcare Conference
05/12 TRANSITION THERAPEUTICS : Announces Third Quarter Fiscal 2015 Financial Results
05/07 TRANSITION THERAPEUTICS : to Hold Conference Call on Third Quarter Fiscal 2015 F..
05/06 TRANSITION THERAPEUTICS : In-Licenses Phase 2 Drug Candidate from Lilly
03/26 TRANSITION THERAPEUTICS : Announces Results from Phase 1 AME & Renal Clearance C..
03/02 TRANSITION THERAPEUTICS : Announces Enrolment Completion of ELND005 Phase 2 Clin..
More news
Sector news : Biopharmaceuticals
05:07a ROCHE BEARER SHARE : Perjeta regimen approved in Europe for use before surgery i..
04:03a EISAI : and Halozyme Sign Collaboration Agreement to Investigate Eribulin and Pe..
03:21a ONO PHARMACEUTICAL : submits manufacturing approval partial amendment applicatio..
More sector news : Biopharmaceuticals
News from SeekingAlpha
07/17 PREMARKET BIOTECH DIGEST : Options Trading, Achillion Short Interest, Opdivo EU ..
06/25 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
06/24 PREMARKET GAINERS / LOSERS AS OF 9 : 10 am
06/24 Transition Therapeutics' lead product candidate flunks mid-stage study; share..
06/16 New President at Transition Therapeutics


Comments 
Advertisement
Chart TRANSITION THERAPEUTICS IN
Duration : Period :
Transition Therapeutics In Technical Analysis Chart | TTH | CA8937162094 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
EPS Revisions
More Estimates Revisions